Werbung
Werbung

CLOV

CLOV logo

Clover Health Investments, Corp

2.59
USD
Gesponsert
+0.06
+2.37%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

2.62

+0.03
+0.97%

CLOV Ergebnisberichte

Positives Überraschungsverhältnis

CLOV übertreffen die 14 der letzten 19Schätzungen.

74%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$476.40M
/
-$0.10
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-4.08%
/
+100.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+41.38%
/
+150.00%

Clover Health Investments, Corp earnings per share and revenue

On 04. Nov. 2025, CLOV reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.03 USD, resulting in a -63.40% surprise. Revenue reached 496.65 million, compared to an expected 480.51 million, with a 3.36% difference. The market reacted with a -15.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 476.40 million USD, implying an increase of 100.00% EPS, and decrease of -4.08% in Revenue from the last quarter.
FAQ
For Q3 2025, Clover Health Investments, Corp reported EPS of -$0.05, missing estimates by -63.4%, and revenue of $496.65M, 3.36% above expectations.
The stock price moved down -15.77%, changed from $3.52 before the earnings release to $2.96 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 5 analysts, Clover Health Investments, Corp is expected to report EPS of -$0.10 and revenue of $476.40M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung